These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

223 related items for PubMed ID: 25180131

  • 1. Treatment of asymptomatic hyperuricemia for the prevention of gouty arthritis, renal disease, and cardiovascular events: a systematic literature review.
    Vinik O, Wechalekar MD, Falzon L, Buchbinder R, van der Heijde DM, Bombardier C.
    J Rheumatol Suppl; 2014 Sep; 92():70-4. PubMed ID: 25180131
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Urate lowering therapy to improve renal outcomes in patients with chronic kidney disease: systematic review and meta-analysis.
    Kanji T, Gandhi M, Clase CM, Yang R.
    BMC Nephrol; 2015 Apr 19; 16():58. PubMed ID: 25928556
    [Abstract] [Full Text] [Related]

  • 4. [Gout and hyperuricaemia--should both be treated?].
    Uhlig T.
    Tidsskr Nor Laegeforen; 2003 Oct 23; 123(20):2878-80. PubMed ID: 14600714
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Caffeoylquinic acid derivatives rich extract from Gnaphalium pensylvanicum willd. Ameliorates hyperuricemia and acute gouty arthritis in animal model.
    Jiang Y, Lin Y, Hu YJ, Song XJ, Pan HH, Zhang HJ.
    BMC Complement Altern Med; 2017 Jun 17; 17(1):320. PubMed ID: 28623927
    [Abstract] [Full Text] [Related]

  • 8. Effect of Urate Lowering Therapy on Renal Disease Progression in Hyperuricemic Patients with Chronic Kidney Disease.
    Kim Y, Shin S, Kim K, Choi S, Lee K.
    J Rheumatol; 2015 Nov 17; 42(11):2143-8. PubMed ID: 26428209
    [Abstract] [Full Text] [Related]

  • 9. A survey of current prescribing practices of antiinflammatory and urate lowering drugs in gouty arthritis in the province of Ontario.
    Bellamy N, Gilbert JR, Brooks PM, Emmerson BT, Campbell J.
    J Rheumatol; 1988 Dec 17; 15(12):1841-7. PubMed ID: 3265960
    [Abstract] [Full Text] [Related]

  • 10. Gouty Arthritis: A Review of Acute Management and Prevention.
    Wilson L, Saseen JJ.
    Pharmacotherapy; 2016 Aug 17; 36(8):906-22. PubMed ID: 27318031
    [Abstract] [Full Text] [Related]

  • 11. [How to select and use urate lowering agents for hyperuricemia].
    Yamanaka H.
    Nihon Rinsho; 1996 Dec 17; 54(12):3261-5. PubMed ID: 8976102
    [Abstract] [Full Text] [Related]

  • 12. A retrospective study of the relationship between serum urate level and recurrent attacks of gouty arthritis: evidence for reduction of recurrent gouty arthritis with antihyperuricemic therapy.
    Shoji A, Yamanaka H, Kamatani N.
    Arthritis Rheum; 2004 Jun 15; 51(3):321-5. PubMed ID: 15188314
    [Abstract] [Full Text] [Related]

  • 13. Difficult-to-treat gouty arthritis: a disease warranting better management.
    Schlesinger N.
    Drugs; 2011 Jul 30; 71(11):1413-39. PubMed ID: 21812506
    [Abstract] [Full Text] [Related]

  • 14. Management of acute and chronic gouty arthritis: present state-of-the-art.
    Schlesinger N.
    Drugs; 2004 Jul 30; 64(21):2399-416. PubMed ID: 15481999
    [Abstract] [Full Text] [Related]

  • 15. Luteolin-4'-O-glucoside and its aglycone, two major flavones of Gnaphalium affine D. Don, resist hyperuricemia and acute gouty arthritis activity in animal models.
    Lin Y, Liu PG, Liang WQ, Hu YJ, Xu P, Zhou J, Pu JB, Zhang HJ.
    Phytomedicine; 2018 Mar 01; 41():54-61. PubMed ID: 29519319
    [Abstract] [Full Text] [Related]

  • 16. Effects of Gnaphalium affine D. Don on hyperuricemia and acute gouty arthritis.
    Zhang HJ, Li LN, Zhou J, Yang QQ, Liu PG, Xu P, Liang WQ, Cheng L, Zhang YQ, Pu JB, Hu YJ.
    J Ethnopharmacol; 2017 May 05; 203():304-311. PubMed ID: 28390941
    [Abstract] [Full Text] [Related]

  • 17. Pharmacotherapy for hyperuricemia in hypertensive patients.
    Gois PH, Souza ER.
    Cochrane Database Syst Rev; 2013 Jan 31; (1):CD008652. PubMed ID: 23440832
    [Abstract] [Full Text] [Related]

  • 18. [Gout].
    Gröbner W, Zöllner N.
    Z Rheumatol; 2004 Feb 31; 63(1):2-9. PubMed ID: 14991273
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.